NHS trust apologises for wrongly giving patients chemotherapy - The Telegraph

Direct Source Verification: This story is aggregated from The Telegraph (telegraph.co.uk). Full reporting rights and copyright belong to the primary publisher.
The Royal College of Physicians (RCP) is conducting a review about a cancer consultant at University Hospital Coventry who is now retired Credit: Alamy Stock Photo/PA Images Telegraph Reporters Published 18 November 2026 11:04am GMT An NHS trust has apologised after it wrongly ga...

The Royal College of Physicians (RCP) is conducting a review about a cancer consultant at University Hospital Coventry who is now retired Credit: Alamy Stock Photo/PA Images Telegraph Reporters Published 18 November 2026 11:04am GMT An NHS trust has apologised after it wrongly gave patients chemotherapy for several years.

Leaders at University Hospitals Coventry and Warwickshire NHS Trust have admitted to “failures” that meant some patients were misdiagnosed with brain tumours and others were wrongly told they would die if they stopped chemotherapy.

The trust asked the Royal College of Physicians (RCP) to conduct a review after doctors at the trust raised the alarm about patients who had received the care of Prof Ian Brown, a cancer consultant at University Hospital Coventry who is now retired.

Prof Andy Hardy, the trust’s chief executive, and Sue Noyes, the trust chairman, said in a statement that meaningful action had been taken to address the concerns detailed in the review.

The statement said: “We are deeply sorry to all the patients and families affected by failures within our neuro-oncology service under the care of retired clinical oncologist Ian Brown.

“We recognise the concern, distress and loss of trust experienced by those who placed their faith in us during some of the most difficult moments of their lives.”

Becky Jones, who was 21 at the time of her misdiagnosis, was subjected to 11 years of unnecessary chemotherapy after she was told she had a terminal brain tumour and months to live.

After more than a decade of invasive treatment that caused her to miss family events and abandon her career, the mother of two found out that she had inflammation of the brain that could have been treated with steroids.

Ms Jones told the BBC “I was told time and time again without the chemotherapy I would die”, adding: “I never had a brain tumour. I was misdiagnosed and I’ve gone through all this treatment for the main part of my adult life, for no reason.”

The 34-year-old is one of more than 40 patients taking legal action against the trust over alleged prolonged or unnecessary cancer treatment.

Becky Jones underwent unnecessary chemotherapy for 11 years after she was wrongly diagnosed with a brain tumour Prof Hardy and Ms Noyes’s statement said the RCP report showed how patients’ chemotherapy treatment “was prolonged beyond accepted national guidance, and that opportunities were missed to challenge and oversee these clinical decisions sooner”.

It continued: “It also, distressingly, shows that some patients experienced harm because of the care they received.

“This is far below the standards our patients deserve and that we expect. We let you down, and for that we offer our sincere apologies.”

The pair said the trust had extended its historical review back to 2005, when national guidance for the chemotherapy drug temozolomide (TMZ) was first published, “to ensure affected patients are identified and supported”.

All living patients receiving TMZ at the trust had already had their care reviewed internally to ensure it aligned with expected standards, the trust added.

A “comprehensive independent external clinical review process” will also evaluate all living patients who received over 12 cycles of TMZ under Prof Brown.

Ms Jones alleged that Prof Brown said she would need the chemotherapy drug temozolomide (TMZ) for the rest of her life, despite guidelines recommending six cycles in six months.

“He’s just ruined my life, essentially,” she said, adding that her concerns over not being able to see the tumour in scan results were dismissed as the consultant said it would not be “visible to the naked eye”.

The statement from Prof Hardy and Ms Noyes added the trust had already taken “decisive steps to strengthen our clinical governance and ensure all treatment decisions are made collaboratively”.

The trust added: “We have initiated discussions with the NHS England regional director of patient safety to establish clear requirements and methodology for reviewing the cohort of deceased patients who received non-standard chemotherapy regime.”

An independent review is also examining “speaking-up processes” to “ensure staff feel fully supported and confident in raising any concerns”.

The trust said anyone currently receiving cancer treatment at the trust could be reassured that it is “safe, effective, and closely monitored and our expert cancer teams are here for you whenever you need us”.

The trust also said that a doctor who worked with Prof Brown, named only as Mr N, had retired from the trust.

It has made a formal regulatory referral regarding Mr N to the Nursing and Midwifery Council regulator.

Original Source
https://www.telegraph.co.uk/news/2026/11/18/nhs-trust-apologises-patients-chemotherapy-coventry/
Visit The Telegraph ↗
SHARE STORY:
𝕏 f in

Related Coverage in Health